The latest data on the early detection of cancer of the cervix is accepted for publication in the International Journal of Modern Cancer Therapy (Issue 1999 Vol. 2 3:1)

Evaluation of the data, shows that a successful use of this new blood screening technique using TMCS as a marker, could provide an important tool for the study of early detection of malignancies in the body. The technique is especially of great value in India as it is cost effective, time saving and easy to perform. Use of this technique for an effective mass screening programme is most likely to result in the down staging of commonly encountered cancers in our country.

As we all know, early detection is the only key factor in treating cancer patients and we hope to use this new screening technique as a proper test to screen and prevent the population against cancer.

The test is going to be available at Grant Medical Foundation’s Ruby Hall Clinic. In the near future interested persons are requested to contact Ruby Hall Clinic at the following Telephone: +91 20 26123391 (Ext. 4408) or send in their enquiries at: This email address is being protected from spambots. You need JavaScript enabled to view it.

	Negative control group	Cancer of Breast	Cancer of Cervix	Cancer of Oral GI tract	Cancer of Oral cavity	Sarcoma
No. of samples studied	787	23	22	32	30	07
Mean	0.101	0.534	0.580	0.755	0.664	0.581
SD	0.070	–	–	–	–	–
Cut–Off	0.243	0.243	0.243	0.243	0.243	0.243
No. of true Negative	961	–	–	–	–	–
No. of true Positive	–	21	22	32	30	07
Specificity	94.8%	–	–	–	–	–
Sensitivity	–	91.3%	100%	100%	100%	100%

Mrs. M. A. Agashe
M. Sc. (Cytology),
Research Officer.